中关村(000931.SZ)：胞磷胆碱钠注射液一致性评价申报获受理

Core Viewpoint - Zhongguancun (000931.SZ) announced that its subsidiary, Duoduo Pharmaceutical Co., Ltd., has received the Acceptance Notice from the National Medical Products Administration for the consistency evaluation application of Sodium Cytidine Injection [1] Group 1: Product Information - The product under application is indicated for: 1) Cerebral blood supply disorders during the acute and subacute phases caused by thrombosis or vascular rupture 2) Conditions resulting from head trauma due to impact [1]